Medical Center Clinical Rotation for Pharmaceutical Drug Information Professionals
- PDF / 299,506 Bytes
- 4 Pages / 504 x 719.759 pts Page_size
- 34 Downloads / 199 Views
0092-8615/2000 Copyright 0 2000 Drug Information Association Inc.
MEDICAL CENTER CLINICAL ROTATION FOR PHARMACEUTICAL DRUG INFORMATION PROFESSIONALS MARTINL. POLLOCK, PHARMD Drug Infomation Services, Parke-Davis, Morris Plains, New Jersey
ANTHONYFAZIO,FHARMD Pharmacy Department, Morristown Memorial Hospital, Morristown, New Jersey
Drug information practitioners can be at a disadvantage in that they do not work directly in patient-care environments. This article describes a clinical rotation program developed to enable Parke-Davis drug information colleagues to experience a contemporary patient care environment at a local medical center. In March 2000, 13 Parke-Davis drug information professionals completed one-day rotations at Morristown Memorial Hospital. The general medicine clinical rotation provided meaningful experience in observing state-ofi the-art health care, helped drug information colleagues better relate to the situations that health professional customers face, fostered more effective communication with health care professionals and patients, and provided a better appreciation of patientcare literature and in preparing drug information-medical communications that refer to and discuss patient care situations. Morristown Memorial Hospital has been invited to participate in a rotation program at Parke-Davis. Key Words: Drug information; Rotation; Medical center
INTRODUCTION THE PARKE-DAVIS drug information prescription products group responded to approximately 136000 inquiries in 1999. During that time, the department was staffed by 21 permanent health care professionals (mostly pharmacists). The staff also included an additional four health care professionals (temporary positions) as well as a number of administrative support personnel. ParkeDavis drug information is divided into therapeutic teams encompassing atherosclerosis,
Reprint address: Martin L. Pollock, PharmD, Office of Post-Marketing Drug Risk Assessment, Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857. E-mail: [email protected].
cardiovascular, central nervous system, diabetes, and women’s health. The teams primarily handle inquiries from health care professionals. In addition, there is another team that handles only inquiries from patients and consumers across all therapeutic areas. The principal products supported by each of the teams is shown in Table 1. As in other pharmaceutical f m s (l), Parke-Davis drug information colleagues also participate in other professional and supportive activities such as developing communications for marketing disease teams, accompanying field sales and medical liaisons, providing in-house presentations on disease states and therapeutics, working with pharmacy student externs, and attending investigator meetings, medical meetings, and professional workshops.
1129
Downloaded from dij.sagepub.com at OAKLAND UNIV on June 15, 2015
1130
Martin L. Pollock and Anthony Fazio
TABLE 1 Products Supported by Each Parke-Davis Drug Information D
